Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 4 Open-market sale EVP, R&D, CSO sold 101,329 shares at an average $9.30 ($942,578)
  2. 4 Grant or award EVP-Technical Operations acquired 12,665 shares (grant or award)
  3. 4 Grant or award Exec. Vice Pres. HR acquired 7,559 shares (grant or award)
  4. 4 Grant or award Exec VP Finance, CFO acquired 13,932 shares (grant or award)
  5. 4 Grant or award EVP,R&D, CSO acquired 16,465 shares (grant or award)
  6. 4 Grant or award CEO & President acquired 37,994 shares (grant or award)
  7. 4 Shares withheld for taxes EVP, R&D, Chief Scientific Off gave up 10,053 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP-Technical Operations gave up 10,053 shares (to pay taxes)
  9. 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 1,191 shares (to pay taxes)
  10. 4 Shares withheld for taxes CEO & President gave up 39,391 shares (to pay taxes)
  11. 4 Shares withheld for taxes Exec VP Finance, CFO gave up 9,446 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes Exec VP Finance, CFO gave up 4,157 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Shares withheld for taxes CEO & President gave up 10,635 shares (to pay taxes)
  20. 4 Shares withheld for taxes Exec VP Finance, CFO gave up 1,063 shares (to pay taxes)

Page 9 of 28 · 560 filings